330 related articles for article (PubMed ID: 32723974)
21. Exploration of Novel Immunological Terms in Lung Cancer With Large Populations: Implications for Immunotherapy.
Yao Y; Wang J; Yang F; Gao W
Front Immunol; 2022; 13():924498. PubMed ID: 35844536
[TBL] [Abstract][Full Text] [Related]
22. Independent Validation of Early-Stage Non-Small Cell Lung Cancer Prognostic Scores Incorporating Epigenetic and Transcriptional Biomarkers With Gene-Gene Interactions and Main Effects.
Zhang R; Chen C; Dong X; Shen S; Lai L; He J; You D; Lin L; Zhu Y; Huang H; Chen J; Wei L; Chen X; Li Y; Guo Y; Duan W; Liu L; Su L; Shafer A; Fleischer T; Moksnes Bjaanæs M; Karlsson A; Planck M; Wang R; Staaf J; Helland Å; Esteller M; Wei Y; Chen F; Christiani DC
Chest; 2020 Aug; 158(2):808-819. PubMed ID: 32113923
[TBL] [Abstract][Full Text] [Related]
23. DNA hypermethylation of microRNA-34b/c has prognostic value for stage Ⅰ non-small cell lung cancer.
Wang Z; Chen Z; Gao Y; Li N; Li B; Tan F; Tan X; Lu N; Sun Y; Sun J; Sun N; He J
Cancer Biol Ther; 2011 Mar; 11(5):490-6. PubMed ID: 21383543
[TBL] [Abstract][Full Text] [Related]
24. Epigenome-wide gene-age interaction analysis reveals reversed effects of
Chen C; Wei Y; Wei L; Chen J; Chen X; Dong X; He J; Lin L; Zhu Y; Huang H; You D; Lai L; Shen S; Duan W; Su L; Shafer A; Fleischer T; Bjaanæs MM; Karlsson A; Planck M; Wang R; Staaf J; Helland Å; Esteller M; Zhang R; Chen F; Christiani DC
Aging (Albany NY); 2020 Jun; 12(11):10642-10662. PubMed ID: 32511103
[TBL] [Abstract][Full Text] [Related]
25. FHIT promoter methylation status, low protein and high mRNA levels in patients with non-small cell lung cancer.
Czarnecka KH; Migdalska-Sęk M; Domańska D; Pastuszak-Lewandoska D; Dutkowska A; Kordiak J; Nawrot E; Kiszałkiewicz J; Antczak A; Brzeziańska-Lasota E
Int J Oncol; 2016 Sep; 49(3):1175-84. PubMed ID: 27572663
[TBL] [Abstract][Full Text] [Related]
26. Gene Methylation Biomarkers in Sputum and Plasma as Predictors for Lung Cancer Recurrence.
Belinsky SA; Leng S; Wu G; Thomas CL; Picchi MA; Lee SJ; Aisner S; Ramalingam S; Khuri FR; Karp DD
Cancer Prev Res (Phila); 2017 Nov; 10(11):635-640. PubMed ID: 28904059
[TBL] [Abstract][Full Text] [Related]
27. Methylated +322-327 CpG site decreases hOGG1 mRNA expression in non-small cell lung cancer.
Zeng Y; Zhu J; Qin H; Shen D; Lei Z; Li W; Ding Z; Huang JA; Liu Z
Oncol Rep; 2017 Jul; 38(1):529-537. PubMed ID: 28586012
[TBL] [Abstract][Full Text] [Related]
28. Statistical and bioinformatic analysis of hemimethylation patterns in non-small cell lung cancer.
Sun S; Zane A; Fulton C; Philipoom J
BMC Cancer; 2021 Mar; 21(1):268. PubMed ID: 33711952
[TBL] [Abstract][Full Text] [Related]
29. Construction of a 5-methylcytosine-Related Molecular Signature to Inform the Prognosis and Immunotherapy of Lung Squamous Cell Carcinoma.
He R; Feng X; Yang K; Zhou X; Li W; Zeng J
Expert Rev Mol Diagn; 2022 Sep; 22(9):905-913. PubMed ID: 36197838
[TBL] [Abstract][Full Text] [Related]
30. The immune response-related mutational signatures and driver genes in non-small-cell lung cancer.
Chen H; Chong W; Teng C; Yao Y; Wang X; Li X
Cancer Sci; 2019 Aug; 110(8):2348-2356. PubMed ID: 31222843
[TBL] [Abstract][Full Text] [Related]
31. Association of Tumor Mutational Burden With DNA Repair Mutations and Response to Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer.
Chae YK; Davis AA; Raparia K; Agte S; Pan A; Mohindra N; Villaflor V; Giles F
Clin Lung Cancer; 2019 Mar; 20(2):88-96.e6. PubMed ID: 30425022
[TBL] [Abstract][Full Text] [Related]
32. Machine-Learning and Stochastic Tumor Growth Models for Predicting Outcomes in Patients With Advanced Non-Small-Cell Lung Cancer.
Siah KW; Khozin S; Wong CH; Lo AW
JCO Clin Cancer Inform; 2019 Sep; 3():1-11. PubMed ID: 31539267
[TBL] [Abstract][Full Text] [Related]
33. Addressing the elephant in the room, therapeutic resistance in non-small cell lung cancer, with epigenetic therapies.
Carter CA; Zeman K; Day RM; Richard P; Oronsky A; Oronsky N; Lybeck M; Scicinski J; Oronsky B
Oncotarget; 2016 Jun; 7(26):40781-40791. PubMed ID: 27007055
[TBL] [Abstract][Full Text] [Related]
34.
Lu J; Zhong R; Lou Y; Hu M; Yang Z; Wang Y; Chen Y; Zou B; Zhang W; Wang H; Han B
Front Immunol; 2021; 12():732125. PubMed ID: 34603310
[TBL] [Abstract][Full Text] [Related]
35. Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non-Small Cell Lung Cancer Using a Clinicogenomic Database.
Singal G; Miller PG; Agarwala V; Li G; Kaushik G; Backenroth D; Gossai A; Frampton GM; Torres AZ; Lehnert EM; Bourque D; O'Connell C; Bowser B; Caron T; Baydur E; Seidl-Rathkopf K; Ivanov I; Alpha-Cobb G; Guria A; He J; Frank S; Nunnally AC; Bailey M; Jaskiw A; Feuchtbaum D; Nussbaum N; Abernethy AP; Miller VA
JAMA; 2019 Apr; 321(14):1391-1399. PubMed ID: 30964529
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling.
Schrock AB; Li SD; Frampton GM; Suh J; Braun E; Mehra R; Buck SC; Bufill JA; Peled N; Karim NA; Hsieh KC; Doria M; Knost J; Chen R; Ou SI; Ross JS; Stephens PJ; Fishkin P; Miller VA; Ali SM; Halmos B; Liu JJ
J Thorac Oncol; 2017 Jun; 12(6):932-942. PubMed ID: 28315738
[TBL] [Abstract][Full Text] [Related]
37. The emerging development of tumor mutational burden in patients with NSCLC.
Zhang Y; Wang L; Li R; Liu B
Future Oncol; 2020 Mar; 16(9):469-481. PubMed ID: 32048882
[TBL] [Abstract][Full Text] [Related]
38. LINE-1 hypomethylation is associated to specific clinico-pathological features in Stage I non-small cell lung cancer.
Imperatori A; Sahnane N; Rotolo N; Franzi F; Nardecchia E; Libera L; Romualdi C; Cattoni M; Sessa F; Dominioni L; Furlan D
Lung Cancer; 2017 Jun; 108():83-89. PubMed ID: 28625654
[TBL] [Abstract][Full Text] [Related]
39. Can aberrant promoter hypermethylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection?
Kim YT; Lee SH; Sung SW; Kim JH
Ann Thorac Surg; 2005 Apr; 79(4):1180-8; discussion 1180-8. PubMed ID: 15797047
[TBL] [Abstract][Full Text] [Related]
40. Genomewide DNA methylation analysis identifies novel methylated genes in non-small-cell lung carcinomas.
Carvalho RH; Hou J; Haberle V; Aerts J; Grosveld F; Lenhard B; Philipsen S
J Thorac Oncol; 2013 May; 8(5):562-73. PubMed ID: 23524404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
